Background: Chronic kidney disease (CKD) is usually progressive, often resulting in end-stage renal disease (ESRD). The two most common causes of renal disease, hypertension and diabetes mellitus contribute greatly to the mobility and mortality associated with CKD. It has been found that lowering BP is effective in reducing cardiovascular events in patient with a moderate reduction in GFR and in those with ESRD on dialysis. The aim of this study was to assess blood pressure control among adult African CKD patients. Method: The case notes of chronic kidney patients who assess care in the renal unit of our Teaching Hospital were retrieved for the study after obtaining informed consent from the ethical unit of the hospital. To be eligible for the study, the patient, must have been attending the renal clinic and on anti-hypertensives for a minimum period of 6 months. Results: Eighty-seven CKD patients (46 males and 41 females) with a mean age of 50.9 ± 13.3 years. The proportion of patients who achieved blood pressure control was 13.79% (95% CI 7.34% - 22.85%). Among the pre-dialysis patients, BP control was achieved in 13.64% compared to 14.29% among the patients on dialysis. Nineteen (21.84%) of the patients were on one blood pressure lowering agent; 26 (29.89%) on two; 33 (37.93%) on three; 7 (8.05%) on four and 2 (2.30%) on five. Conclusion: Blood pressure control among African adult CKD patients is difficult with many of them requiring more than two antihypertensive drugs.
KeywordsBlood PressureControl. CKDAfrica
Besarab, A., Bolton, W.K., Browne, J.K., et al. (1998) The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin. The New England Journal of Medicine, 339, 584-590. https://doi.org/10.1056/NEJM199808273390903
Eknoyan, G., Beck, G.J., Cheung, A.K., et al. (2002) Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis. The New England Journal of Medicine, 347, 2010-2019. https://doi.org/10.1056/NEJMoa021583
Paniagua, R., Amato, D., Vonesh, E., et al. (2002) Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial. Journal of the American Society of Nephrology, 13, 1307-1320.
Foley, R.N., Parfrey, P.S., Harnett, J.D., et al. (1995) Clinical and Echocardiographic Disease in Patients Starting End-Stage Renal Disease Therapy. Kidney International, 47, 186-192. https://doi.org/10.1038/ki.1995.22
Ninomiya, T., Perkovic, V., Turnbull, F., et al. (2013) Blood Pressure Lowering and Major Cardiovascular Events in People with and without Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials. BMJ, 347, F5680. https://doi.org/10.1136/bmj.f5680
Elaine, K., David, V.G., Kirsten, L.J., Mark, S., Hocine, T., Barbara, G. and Chi-yuan, H. (2015) Association between Strict Blood Pressure Control during Chronic Kidney Disease and Lower Mortality after Onset of End-Stage Renal Disease. Kidney International, 87, 1055-1060. https://doi.org/10.1038/ki.2014.376
Wright, J.T., Bakris, G., Greene, T., et al. (2002) Effect of Blood Pressure Lowering and Anti-hypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results from the AASK Trial. JAMA, 288, 2421-2431. https://doi.org/10.1001/jama.288.19.2421
Ruggenenti, P., Perna, A., Loriga, G., et al. (2005) Blood-Pressure Control for Renoprotection in Patients with Non-Diabetic Chronic Renal Disease (REIN-2): Multicentre, Randomised Controlled Trial. The Lancet, 365, 939-946. https://doi.org/10.1016/S0140-6736(05)71082-5
The Sprint Research Group (2015) A Randomized Trial of Intensive versus Standard Blood Pressure Control. The New England Journal of Medicine, 373, 2103-2116. https://doi.org/10.1056/NEJMoa1511939
Jhee, J.H., Park, J., Kim, H., et al. (2018) The Optimal Blood Pressure Target in Different Dialysis Populations. Scientific Reports, 8, Article No. 1412. https://doi.org/10.1038/s41598-018-32281-w
Sarafidis, P.A., Persu, A., et al. (2017) Hypertension in Dialysis Patients: A Consensus Document by the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney Working Group of the European Society of Hypertension (ESH). Nephrology Dialysis Transplantation, 32, 620-640. https://doi.org/10.1093/ndt/gfw433
McCallum, W. and Sarnak, M.J. (2019) Blood Pressure Target for the Dialysis Patient. Seminars in Dialysis, 32, 35-40. https://doi.org/10.1111/sdi.12754
Myers, O.B., Adams, C., Rohrscheib, M.R., et al. (2010) Age, Race, Diabetes, Blood Pressure, and Mortality among Hemodialysis Patients. American Society of Nephrology, 21, 1970-1978. https://doi.org/10.1681/ASN.2010010125
National Population Commission of Nigeria (Web), National Bureau of Statistics (Web).
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group (2012) KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney International, 2, 337-414.
Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N. and Roth, D. (1999) A More Accurate Method to Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine, 130, 461-470. https://doi.org/10.7326/0003-4819-130-6-199903160-00002
Wheaton, P.K., Carey, R.M., Aronow, W.S., Casey Jr., D.E., Karen, J., et al. (2018) ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, e13-e115. https://doi.org/10.1016/j.jacc.2017.11.006
Altun, B., Süleymanlar, G., Utas, C., Arinsoy, T., Ates, K., Ecder, T., Camsari, T. and Serdengeçti, K. (2012) Prevalence, Awareness, Treatment and Control of Hypertension in Adults with Chronic Kidney Disease in Turkey: Results from the CREDIT Study. Kidney and Blood Pressure Research, 36, 36-46. https://doi.org/10.1159/000339025
Tanner, R.M., Calhoun, D.A., Bell, E.K., et al. (2013) Prevalence of Apparent Treatment-Resistant Hypertension among Individuals with CKD. Clinical Journal of the American Society of Nephrology, 8, 1583-1590. https://doi.org/10.2215/CJN.00550113
Tattersall, J., Martin-Malo, A., Pedrini, L., et al. (2007) EBPG Guideline on Dialysis Strategies. Nephrology Dialysis Transplantation, 22, ii5-ii21. https://doi.org/10.1093/ndt/gfm022
Adejumo, O., Okaka, E. and Iyawe, I. (2017) Prescription Pattern of Antihypertensive Medications and Blood Pressure Control among Hypertensive Outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria. Malawi Medical Journal, 29, 113-117. https://doi.org/10.4314/mmj.v29i2.7
Tepel, M., Hopfenmueller, W., Scholze, A., et al. (2008) Effect of Amlodipine on Cardiovascular Events in Hypertensive Haemodialysis Patients. Nephrology Dialysis Transplantation, 23, 3605-3612. https://doi.org/10.1093/ndt/gfn304
Douglas, J.G., Bakris, G.L., Epstein, M., Ferdinand, K.C., Ferrario, C., Flack, J.M., Jamerson, K.A., Jones, W.E., Haywood, J., Maxey, R., Ofili, E.O., Saunders, E., Schiffrin, E.L., Sica, D., Sowers, J.R. and Vidt, D.G. (2003) Management of High Blood Pressure in African Americans: A Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Archives of Internal Medicine, 163, 525-541. https://doi.org/10.1001/archinte.163.5.525
Thomopoulous, C., Parati, G. and Zanchetti, A. (2015) Effects of Blood Pressure Outcome Incidence in Hypertension. 4. Effects of Various Classes of Antihypertensive Drugs—Overview and Meta-Analyses. Journal of Hypertension, 33, 195-211. https://doi.org/10.1097/HJH.0000000000000447
Bakris, G., Sarafidis, P.A., Weir, M.R., et al. (2010) Renal Outcomes with Different Fixed-Dose Combination Therapies in Patients with Hypertension at High Risk of Cardiovascular Event (Accomplish): A Prespecified Secondary Analysis of Randomized Controlled Trial. The Lancet, 375, 1173-1181. https://doi.org/10.1016/S0140-6736(09)62100-0
Hsu, T.W., Liu, J.S., Hung, S.C., et al. (2014) Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients with Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia. JAMA Internal Medicine, 174, 347-354. https://doi.org/10.1001/jamainternmed.2013.12700
Chobanian, A.V., Bakris, G.L., Black, H.R., et al. (2003) The National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42, 1206-1252. https://doi.org/10.1161/01.HYP.0000107251.49515.c2
Busari, O.A., Olanrewaju, T.O., Desalu, O.O., Opadijo, G.O., Jimoh, A.K., Agboola, S.M., et al. (2010) Impact of Knowledge, Attitude and Practices on Hypertension on Compliance with Antihypertensive in a Resource-Poor Setting. TAF Preventive Medicine Bulletin, 9, 87-92.
Busari, O.A., Oluyombo, R., Fasae, A.J., Gabriel, E.O., Ayodele, L.M., Agboola, S.M., et al. (2014) Prescribing Pattern and Utilization of Antihypertensive Drugs and Blood Pressure Control in Adults Patients with Systemic Hypertension in a Rural Tertiary Hospital in Nigeria. American Journal of Internal Medicine, 2, 144-149. https://doi.org/10.11648/j.ajim.20140206.18